Physician profile
Vivian Look
NPI 1124672399
$152,192.46
in general payments reported to CMS, 2019-2025
10 companies · $151K in 2025
The $151K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $530 · 2021: $68.88 · 2022: $149 · 2023: $168 · 2024: $274 · 2025: $151K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $151K · Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $150,750.00 |
| Food and Beverage | $540.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $150,750.00 | 2025 | |
| Alcon Vision LLC | $443.10 | 2020-2025 | Precision7 |
| Coopervision INC. | $298.00 | 2021-2024 | Myday Contact Lens, Paragon Crt |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $228.06 | 2019-2020 | |
| Allergan, INC. | $117.57 | 2020 | |
| Rxsight INC | $114.02 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Astellas Pharma US INC | $111.56 | 2024 | Izervay |
| Johnson & Johnson Vision Care, INC. | $96.44 | 2019-2024 | Acuvue |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Abb Con-Cise Optical Group LLC | $14.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivian Look listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.